SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer
Clinical trial NCT05160896 · UNKNOWN
Trial details
- NCT number
- NCT05160896
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-12
- Primary completion
- 2023-06-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.